Live courses

Titlesort ascending Credit Cost Dates
NCCN Pharmacy Updates: Updates on Targeted Therapy in the Treatment of Metastatic Colorectal Cancer
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 Participation
$0.00 04/06/2021 - 1:00pm to 2:00pm
NCCN Pharmacy Updates: Updates in the Treatment of Pancreatic Adenocarcinoma
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 Participation
$0.00 03/11/2021 - 1:00pm to 2:00pm
NCCN Pharmacy Updates: Novel Agents for the Treatment of Relapsed/Refractory Multiple Myeloma
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 Participation
$0.00 06/09/2021 - 12:00pm to 1:00pm
NCCN Pharmacy Updates: New Developments in the Management of Metastatic Bladder Cancer
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 Participation
$0.00 05/11/2021 - 2:30pm to 3:30pm
NCCN Pharmacy Updates: Emerging Strategies for Pediatric Hodgkin Lymphoma Treatment
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 Participation
$0.00 06/23/2021 - 2:00pm to 3:00pm

Pages

Featured courses

Titlesort ascending Credit Type Event date Cost
New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance
    • 1.75 AAPA Category 1 CME credit
    • 1.75 ACPE contact hours
    • 1.75 AMA PRA Category 1 Credit™
    • 1.75 ANCC contact hours
    • 1.75 Participation
Enduring $0.00
New Approaches to Multiple Myeloma Therapy
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 Participation
Enduring $0.00
Chronic Lymphocytic Leukemia Patient Management Simulator Enduring $0.00
Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy
    • 2.00 AAPA Category 1 CME credit
    • 2.00 ACPE contact hours
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 ANCC contact hours
    • 2.00 Participation
Enduring $0.00
AML: Using Available Evidence and Guidelines to Make Sense of a Rapidly Evolving Treatment Paradigm
    • 2.50 AAPA Category 1 CME credit
    • 2.50 ACPE contact hours
    • 2.50 AMA PRA Category 1 Credit™
    • 2.50 ANCC contact hours
    • 2.50 Participation
Enduring $0.00

Transcript

Please login or create an account to view your activities.

Pending Activities

Please login or create an account to view your activities.